Small cell carcinoma of the lung other diagnostic studies: Difference between revisions
No edit summary |
No edit summary |
||
| (2 intermediate revisions by 2 users not shown) | |||
| Line 3: | Line 3: | ||
{{CMG}} | {{CMG}} | ||
==Overview== | ==Overview== | ||
Among patients with small cell lung cancer (SCLC) who have [[pleural effusion]] large enough to be sampled, [[thoracentesis]] should be performed. | Among patients with small cell lung cancer (SCLC) who have [[pleural effusion]] large enough to be sampled, [[thoracentesis]] should be performed. The results of the analysis of the [[pleural effusion]] should be considered in the staging of the lesion. In addition, [[pathological]] [[mediastinal]] staging in selected patients should be performed through either [[mediastinoscopy]], video assisted [[thoracoscopy]], or endobronchial/[[esophageal]] guided [[ultrasound]] [[biopsy]]. Moreover, [[bone marrow biopsy]] is required among SCLC who have evidence on [[blood smear]] of nucleated [[red blood cells]], [[neutropenia]], or [[thrombocytopenia]]. | ||
== Other Diagnostic Studies == | |||
< | * Among patients with small cell lung cancer (SCLC) who have [[pleural effusion]] large enough to be sampled, [[thoracentesis]] should be performed.<ref name="NCCN">[http://www.nccn.org/professionals/physician_gls/f_guidelines_nojava.asp NCCN Clinical Practice Guidelines in Oncology. Small Cell Lung Cancer, version 2.2014] </ref> | ||
* The results of the analysis of the [[pleural effusion]] should be considered in the [[Cancer staging|staging]] of the [[lesion]].<ref name="NCCN" /> | |||
* [[Pathological]] [[mediastinal]] staging in selected patients should be performed through either [[mediastinoscopy]], video assisted [[thoracoscopy]], or endobronchial/[[esophageal]] guided [[ultrasound]] [[biopsy]]. | |||
* [[Bone marrow biopsy]] is required among SCLC who have evidence on [[blood smear]] of nucleated [[red blood cells]], [[neutropenia]], or [[thrombocytopenia]]. | |||
</ | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
Latest revision as of 23:32, 4 September 2019
|
Small Cell Carcinoma of the Lung Microchapters |
|
Differentiating Small Cell Carcinoma of the Lung from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Small cell carcinoma of the lung other diagnostic studies On the Web |
|
American Roentgen Ray Society Images of Small cell carcinoma of the lung other diagnostic studies |
|
FDA on Small cell carcinoma of the lung other diagnostic studies |
|
CDC on Small cell carcinoma of the lung other diagnostic studies |
|
Small cell carcinoma of the lung other diagnostic studies in the news |
|
Blogs on Small cell carcinoma of the lung other diagnostic studies |
|
Directions to Hospitals Treating Small cell carcinoma of the lung |
|
Risk calculators and risk factors for Small cell carcinoma of the lung other diagnostic studies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Among patients with small cell lung cancer (SCLC) who have pleural effusion large enough to be sampled, thoracentesis should be performed. The results of the analysis of the pleural effusion should be considered in the staging of the lesion. In addition, pathological mediastinal staging in selected patients should be performed through either mediastinoscopy, video assisted thoracoscopy, or endobronchial/esophageal guided ultrasound biopsy. Moreover, bone marrow biopsy is required among SCLC who have evidence on blood smear of nucleated red blood cells, neutropenia, or thrombocytopenia.
Other Diagnostic Studies
- Among patients with small cell lung cancer (SCLC) who have pleural effusion large enough to be sampled, thoracentesis should be performed.[1]
- The results of the analysis of the pleural effusion should be considered in the staging of the lesion.[1]
- Pathological mediastinal staging in selected patients should be performed through either mediastinoscopy, video assisted thoracoscopy, or endobronchial/esophageal guided ultrasound biopsy.
- Bone marrow biopsy is required among SCLC who have evidence on blood smear of nucleated red blood cells, neutropenia, or thrombocytopenia.